Suppr超能文献

胰腺癌发病机制和治疗抵抗中的肿瘤微环境。

Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance.

机构信息

Department of Cell, Developmental and Cancer Biology; and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email:

Abramson Cancer Center; and Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; email:

出版信息

Annu Rev Pathol. 2023 Jan 24;18:123-148. doi: 10.1146/annurev-pathmechdis-031621-024600. Epub 2022 Sep 21.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) features a prominent stromal microenvironment with remarkable cellular and spatial heterogeneity that meaningfully impacts disease biology and treatment resistance. Recent advances in tissue imaging capabilities, single-cell analytics, and disease modeling have shed light on organizing principles that shape the stromal complexity of PDAC tumors. These insights into the functional and spatial dependencies that coordinate cancer cell biology and the relationships that exist between cells and extracellular matrix components present in tumors are expected to unveil therapeutic vulnerabilities. We review recent advances in the field and discuss current understandings of mechanisms by which the tumor microenvironment shapes PDAC pathogenesis and therapy resistance.

摘要

胰腺导管腺癌(PDAC)的特征是明显的基质微环境,具有显著的细胞和空间异质性,这对疾病生物学和治疗耐药性有重要影响。组织成像能力、单细胞分析和疾病建模方面的最新进展揭示了组织学特征,这些特征决定了 PDAC 肿瘤基质的复杂性。这些对协调癌细胞生物学的功能和空间依赖性的见解,以及肿瘤中细胞与细胞外基质成分之间存在的关系的理解,有望揭示治疗弱点。我们回顾了该领域的最新进展,并讨论了肿瘤微环境影响 PDAC 发病机制和治疗耐药性的机制的现有认识。

相似文献

1
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance.
Annu Rev Pathol. 2023 Jan 24;18:123-148. doi: 10.1146/annurev-pathmechdis-031621-024600. Epub 2022 Sep 21.
2
The biological underpinnings of therapeutic resistance in pancreatic cancer.
Genes Dev. 2021 Jul 1;35(13-14):940-962. doi: 10.1101/gad.348523.121. Epub 2021 Jun 11.
3
The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment.
Am J Pathol. 2019 Jan;189(1):44-57. doi: 10.1016/j.ajpath.2018.09.009.
5
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Expert Opin Investig Drugs. 2019 Feb;28(2):161-177. doi: 10.1080/13543784.2019.1557145. Epub 2018 Dec 16.
6
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Adv Drug Deliv Rev. 2021 May;172:37-51. doi: 10.1016/j.addr.2021.02.012. Epub 2021 Mar 8.
7
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.
Gastroenterology. 2022 Aug;163(2):386-402.e1. doi: 10.1053/j.gastro.2022.03.056. Epub 2022 Apr 7.
8
Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Chin Clin Oncol. 2019 Apr;8(2):18. doi: 10.21037/cco.2019.03.02.
10
Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma.
Cell Oncol (Dordr). 2024 Oct;47(5):1561-1578. doi: 10.1007/s13402-024-00970-6. Epub 2024 Jul 15.

引用本文的文献

2
Hypoxia promotes pancreatic adenocarcinoma progression by stabilizing ID1 via TRIM21 suppression.
Front Oncol. 2025 Aug 21;15:1616968. doi: 10.3389/fonc.2025.1616968. eCollection 2025.
3
8
HRASLS2 promotes the growth and glycolysis of pancreatic cancer by enhancing the stability of ASPH.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 20. doi: 10.1007/s00210-025-04522-z.
10
Decoding the tumor microenvironment: insights into immunotherapy and beyond.
J Natl Cancer Cent. 2025 Apr 28;5(4):426-428. doi: 10.1016/j.jncc.2025.04.003. eCollection 2025 Aug.

本文引用的文献

1
Cancer statistics, 2022.
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
2
CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis.
Oncogene. 2022 Feb;41(7):971-982. doi: 10.1038/s41388-021-02132-6. Epub 2022 Jan 10.
3
Tertiary lymphoid structures in cancer.
Science. 2022 Jan 7;375(6576):eabf9419. doi: 10.1126/science.abf9419.
4
Hyaluronic acid fuels pancreatic cancer cell growth.
Elife. 2021 Dec 24;10:e62645. doi: 10.7554/eLife.62645.
5
Spatially confined sub-tumor microenvironments in pancreatic cancer.
Cell. 2021 Oct 28;184(22):5577-5592.e18. doi: 10.1016/j.cell.2021.09.022. Epub 2021 Oct 12.
6
Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts.
Cancer Discov. 2022 Feb;12(2):484-501. doi: 10.1158/2159-8290.CD-21-0601. Epub 2021 Sep 21.
7
Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Cell. 2021 Sep 16;184(19):5031-5052.e26. doi: 10.1016/j.cell.2021.08.023.
8
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.
Science. 2021 Sep 17;373(6561):eabj0486. doi: 10.1126/science.abj0486.
9
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity.
Cancer Cell. 2021 Sep 13;39(9):1227-1244.e20. doi: 10.1016/j.ccell.2021.06.017. Epub 2021 Jul 22.
10
Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer.
Nat Cancer. 2020 Nov;1(11):1097-1112. doi: 10.1038/s43018-020-00121-4. Epub 2020 Oct 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验